CSL - Ebit

Stock Price
145.00
Daily Change
-2.38 -1.61%
Monthly
-20.73%
Yearly
-44.76%
Q1 Forecast
150.05

CSL reported $2.75B in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Arca Biopharma USD -25.09M 5.23M Mar/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
Bio Path USD -3.24M 616K Mar/2025
Brainstorm Cell Therapeutics USD -3.09M 100K Mar/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
CSL USD 2.75B 1.35B Dec/2024
Curis USD -12.37M 230K Sep/2023
Esperion Therapeutics USD -16.03M 11.51M Sep/2024
Immunic USD -22.81M 756K Jun/2024
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
TherapeuticsMD USD -1.77M 699K Sep/2023